BioCardia, Inc. BCDA
BCDA
BioCardia, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock ACXP
Acurx Pharmaceuticals, Inc. ANEB
Anebulo Pharmaceuticals, Inc. ARDS
Aridis Pharmaceuticals, Inc. HOTH
Hoth Therapeutics, Inc. IMMP
Immutep Limited LIXT
Lixte Biotechnology Holdings, Inc. PHIO
Phio Pharmaceuticals Corp. RNXT
RenovoRx, Inc.
BioCardia, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock ACXP
Acurx Pharmaceuticals, Inc. ANEB
Anebulo Pharmaceuticals, Inc. ARDS
Aridis Pharmaceuticals, Inc. HOTH
Hoth Therapeutics, Inc. IMMP
Immutep Limited LIXT
Lixte Biotechnology Holdings, Inc. PHIO
Phio Pharmaceuticals Corp. RNXT
RenovoRx, Inc.
Performance
| Periode | BCDA | ACRV | ACXP | ANEB | ARDS | HOTH | IMMP | LIXT | PHIO | RNXT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -24.39 % | -19.07 % | -0.13 % | 158.95 % | 100.00 % | 90.97 % | 38.41 % | 258.87 % | -8.64 % | 21.11 % |
| YTD | -31.42 % | -69.42 % | -54.82 % | 55.70 % | 100.00 % | 99.97 % | -5.43 % | 100.45 % | 16.84 % | -19.85 % |
| 1Y | -36.48 % | -77.11 % | -81.40 % | 29.47 % | 100.00 % | 73.72 % | 1.46 % | 147.22 % | -19.57 % | 10.09 % |
| 3Y | -98.31 % | -89.54 % | -86.96 % | -5.38 % | -99.98 % | -80.87 % | 7.73 % | -17.59 % | -96.35 % | -40.44 % |
| 5Y | -98.55 % | -89.54 % | -95.19 % | -65.35 % | -100.00 % | -96.58 % | -63.14 % | -93.66 % | -99.05 % | -84.99 % |
| 10Y | -99.60 % | -89.54 % | -95.19 % | -65.35 % | -100.00 % | -99.28 % | -84.96 % | -53.65 % | -100.00 % | -84.99 % |
| From the beginning | -100.00 % | -89.54 % | -95.19 % | -65.35 % | -100.00 % | -99.28 % | -98.44 % | -99.84 % | -99.30 % | -84.99 % |